• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸氨溴索骨架片的体外特性研究及其直接压片释放度研究。

In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.

机构信息

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

出版信息

Pharm Dev Technol. 2012 Sep-Oct;17(5):562-73. doi: 10.3109/10837450.2011.557728. Epub 2011 Mar 23.

DOI:10.3109/10837450.2011.557728
PMID:21428699
Abstract

A series of either hydrophilic or hydrophobic polymers were used to prepare controlled release Ambroxol hydrochloride (AMX) matrix tablets by direct compression. Both the compatibility and flow properties of AMX/polymer mixtures were investigated. The effect of the amount and type of polymer on the physical properties and in vitro drug release was studied and compared to commercially available Ambroxol(®) SR capsules. A kinetic study of the release profile of AMX from the prepared matrix tablets was performed. All excipients used in the study were compatible with the model drug. AMX/drug mixtures containing sodium alginate (NA) and hydroxypropylmethyl cellulose (HPMC) showed better flow properties than other polymers used in the study. The in vitro drug release studies showed that matrix tablets formulae containing 10% HPMC (S7) or a combination of 30% NA and 5% HPMC (Ah) exhibited a higher ability to control the release of AMX. The kinetic study revealed that a diffusion controlled mechanism prevailed except when carbopol was used. Formula Ah followed a non-fickian diffusion mechanism similar to Ambroxol(®) SR capsules. Both formulae S7 and Ah could be considered as potential candidates for formulation of AMX controlled release matrix tablets.

摘要

一系列亲水性或疏水性聚合物被用于通过直接压缩制备盐酸氨溴索(AMX)的控制释放基质片剂。研究了 AMX/聚合物混合物的相容性和流动性能。研究了聚合物的用量和类型对物理性质和体外药物释放的影响,并与市售的 Ambroxol(®) SR 胶囊进行了比较。对从制备的基质片剂中释放的 AMX 的释放曲线进行了动力学研究。研究中使用的所有辅料与模型药物相容。含有海藻酸钠(NA)和羟丙基甲基纤维素(HPMC)的 AMX/药物混合物显示出比研究中使用的其他聚合物更好的流动性能。体外药物释放研究表明,含有 10% HPMC(S7)或 30% NA 和 5% HPMC 的组合(Ah)的基质片剂配方具有更高的控制 AMX 释放的能力。动力学研究表明,除了使用卡波姆外,扩散控制机制占主导地位。Ah 配方遵循类似于 Ambroxol(®) SR 胶囊的非菲克扩散机制。配方 S7 和 Ah 都可以被认为是 AMX 控制释放基质片剂制剂的潜在候选者。

相似文献

1
In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.盐酸氨溴索骨架片的体外特性研究及其直接压片释放度研究。
Pharm Dev Technol. 2012 Sep-Oct;17(5):562-73. doi: 10.3109/10837450.2011.557728. Epub 2011 Mar 23.
2
[Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].[盐酸氨溴索缓释骨架片的研究及不同填充剂对骨架片放大生产的潜在影响]
Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Oct 18;44(5):742-8.
3
Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.盐酸环丙沙星控制释放型泡腾漂浮型基质片的研制、优化及在健康人体志愿者的体内外评价。
Eur J Pharm Biopharm. 2010 Feb;74(2):332-9. doi: 10.1016/j.ejpb.2009.11.010. Epub 2009 Nov 22.
4
Gastric floating matrix tablets: design and optimization using combination of polymers.胃漂浮型骨架片:基于聚合物组合的设计与优化
Acta Pharm. 2008 Jun;58(2):221-9. doi: 10.2478/v10007-008-0006-3.
5
Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.采用响应面法优化盐酸尼卡地平缓释骨架片的非pH依赖释放
Int J Pharm. 2005 Jan 31;289(1-2):87-95. doi: 10.1016/j.ijpharm.2004.10.021. Epub 2004 Dec 25.
6
A novel system for three-pulse drug release based on "tablets in capsule" device.一种基于“胶囊内片剂”装置的新型三脉冲药物释放系统。
Int J Pharm. 2008 Mar 20;352(1-2):159-64. doi: 10.1016/j.ijpharm.2007.10.043. Epub 2007 Nov 4.
7
[Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].[几种用于亲水性骨架片的聚合物材料特性比较]
Yao Xue Xue Bao. 2011 Mar;46(3):338-43.
8
Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.聚丙稀酰胺-g-海藻酸钠共聚物及其部分水解共聚物基质片的制备及其对盐酸地尔硫卓的缓释评价。
J Biomater Sci Polym Ed. 2010;21(13):1799-814. doi: 10.1163/092050609X12567183711214. Epub 2010 Jun 16.
9
Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.盐酸普萘洛尔亲水骨架片中含有亲水聚合物的车前子粉末的释放行为。
AAPS PharmSciTech. 2011 Dec;12(4):1176-82. doi: 10.1208/s12249-011-9687-x. Epub 2011 Sep 15.
10
Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.采用中心复合设计优化琥珀酸美托洛尔缓释骨架片
Pak J Pharm Sci. 2013 Sep;26(5):929-37.

引用本文的文献

1
Microenvironmental pH-modified Amisulpride-Labrasol matrix tablets: development, optimization and in vivo pharmacokinetic study.微环境 pH 值修饰的安舒必利-拉索醇基质片:开发、优化及体内药代动力学研究。
Drug Deliv Transl Res. 2021 Feb;11(1):103-117. doi: 10.1007/s13346-019-00706-2.